Cargando…
Identification of miRNA Signature in Breast Cancer to Predict Neoadjuvant Chemotherapy Response
Background: Chemotherapy failure causes high breast cancer recurrence and poor patient prognosis. Thus, we studied a cohort of novel biomarkers to predict chemotherapeutic response in breast cancer. In this study, miRNA expression profiling was performed on 10 breast cancer punctured specimens sensi...
Autores principales: | Xing, Ai-Yan, Wang, Bin, Li, Yu-Hong, Chen, Xu, Wang, Ya-Wen, Liu, Hai-Ting, Gao, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262148/ https://www.ncbi.nlm.nih.gov/pubmed/34257614 http://dx.doi.org/10.3389/pore.2021.1609753 |
Ejemplares similares
-
High GP73 Expression Correlates with Poor Response to Neoadjuvant Chemotherapy and Survival in Gastric Cancer: A Tissue Microarray Study
por: Shen, Jian Guo, et al.
Publicado: (2021) -
Pathologic Complete Response Rates After Neoadjuvant Pertuzumab and Trastuzumab with Chemotherapy in Early Stage HER2-Positive Breast Cancer - Increasing Rates of Breast Conserving Surgery: A Real-World Experience
por: Boér, Katalin, et al.
Publicado: (2021) -
Identification of DNA-Repair-Related Five-Gene Signature to Predict Prognosis in Patients with Esophageal Cancer
por: Wang, Lin, et al.
Publicado: (2021) -
Identification of a Novel Epithelial–Mesenchymal Transition Gene Signature Predicting Survival in Patients With HNSCC
por: Xin, Wei, et al.
Publicado: (2021) -
Development of a Novel Prognostic Signature Based on Antigen Processing and Presentation in Patients with Breast Cancer
por: Qi, Aoshuang, et al.
Publicado: (2021)